DBPR108

DRUG3 trials

Sponsors

National Health Research Institutes, Taiwan, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 1

A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects

CompletedNCT01650324

National Health Research Institutes, TaiwanDiabetes Mellitus, Type 2

Start: 2012-07-31End: 2012-12-31Updated: 2014-08-28

A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects

CompletedNCT02163278

National Health Research Institutes, TaiwanDiabetes Mellitus, Type 2

Start: 2014-06-30End: 2015-01-31Updated: 2016-03-28

Phase 3

A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM

CompletedNCT04218734

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Type 2 Diabetes Mellitus

Start: 2020-01-14End: 2021-06-03Updated: 2021-06-28